[go: up one dir, main page]

MX2015015132A - Composiciones farmaceuticas inhalables y los dispositivos inhaladores que las contienen. - Google Patents

Composiciones farmaceuticas inhalables y los dispositivos inhaladores que las contienen.

Info

Publication number
MX2015015132A
MX2015015132A MX2015015132A MX2015015132A MX2015015132A MX 2015015132 A MX2015015132 A MX 2015015132A MX 2015015132 A MX2015015132 A MX 2015015132A MX 2015015132 A MX2015015132 A MX 2015015132A MX 2015015132 A MX2015015132 A MX 2015015132A
Authority
MX
Mexico
Prior art keywords
mass
pharmaceutical compositions
devices containing
inhaler devices
inhalable pharmaceutical
Prior art date
Application number
MX2015015132A
Other languages
English (en)
Inventor
Yorick Kamlag
Mathias Keil
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of MX2015015132A publication Critical patent/MX2015015132A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0001—Details of inhalators; Constructional features thereof
    • A61M15/0021—Mouthpieces therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0065—Inhalators with dosage or measuring devices
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0091—Inhalators mechanically breath-triggered
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/06—Solids
    • A61M2202/064—Powder

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Anesthesiology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Otolaryngology (AREA)
  • Biophysics (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Inorganic Chemistry (AREA)
  • Containers And Packaging Bodies Having A Special Means To Remove Contents (AREA)

Abstract

Una composición farmacéutica adecuada para usarse en un inhalador de polvo seco, la cual comprende del 70 por ciento en masa al 99.5 por ciento en masa de un portador farmacéuticamente aceptable adecuado para usarse en una formulación de inhalación de polvo seco, y del 0.1 por ciento en masa al 12.5 por ciento en masa de xinafoato de salmeterol, y del 0.4 por ciento en masa al 17.5 por ciento en masa de propionato de fluticasona.
MX2015015132A 2013-04-29 2014-04-28 Composiciones farmaceuticas inhalables y los dispositivos inhaladores que las contienen. MX2015015132A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP13165786 2013-04-29
PCT/EP2014/058613 WO2014177519A1 (en) 2013-04-29 2014-04-28 Inhalable pharmaceutical compositions and the inhaler devices containing them

Publications (1)

Publication Number Publication Date
MX2015015132A true MX2015015132A (es) 2016-02-18

Family

ID=48190326

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2015015132A MX2015015132A (es) 2013-04-29 2014-04-28 Composiciones farmaceuticas inhalables y los dispositivos inhaladores que las contienen.

Country Status (12)

Country Link
US (1) US20160158149A1 (es)
EP (1) EP2991625A1 (es)
JP (1) JP2016519123A (es)
KR (1) KR20160003183A (es)
CN (1) CN105324107A (es)
AU (1) AU2014261538A1 (es)
BR (1) BR112015027017A2 (es)
HK (1) HK1215388A1 (es)
MX (1) MX2015015132A (es)
RU (1) RU2015150970A (es)
WO (1) WO2014177519A1 (es)
ZA (1) ZA201507373B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2991626A1 (en) * 2013-04-29 2016-03-09 Sanofi SA Inhalable pharmaceutical compositions and the inhaler devices containing them
NZ741007A (en) * 2014-05-15 2022-12-23 Angel Playing Cards Co Ltd Card shooter device and card storage method
CN106267484A (zh) * 2016-08-08 2017-01-04 中山市美捷时包装制品有限公司 一种干粉吸入装置的定量供料机构
WO2018047013A1 (en) 2016-09-12 2018-03-15 St Ip Holding Ag Formulations of 4-methyl-5-(pyrazin-2-yl)-3h-1, 2-dithiole-3-thione, and methods of making and using same
WO2018047002A1 (en) 2016-09-12 2018-03-15 St Ip Holding Ag Formulations of 4-methyl-5-(pyrazin-2-yl)-3h-1.2-dithiole-3-thione, taste-modified formulations, and methods of making and using same
WO2019171174A2 (en) 2018-03-07 2019-09-12 St Ip Holding Ag Combination compositions and therapies comprising 4-methyl-5-(pyrazin-2-yl)-3h-1,2-dithiole-3-thione, and methods of making and using same
CA3113169A1 (en) 2018-09-18 2020-03-26 St Ip Holding Ag Rotomeric isomers of 4-alkyl-5-heteroaryl-3h-1,2-dithiole-3-thiones
WO2021186244A1 (en) 2020-03-16 2021-09-23 St Ip Holding Ag Rotomeric isomers of 4-alkyl-5-heteroaryl-3h-1,2-dithiole-3-thiones
US11135220B1 (en) 2020-04-08 2021-10-05 St Ip Holding Ag Methods of treating viral infections with formulated compositions comprising 4-methyl-5-(pyrazin-2-yl)-3H-1,2-dithiole-3-thione

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL95590A (en) * 1989-09-08 1996-06-18 Glaxo Group Ltd Medicinal preparations containing Salmetrol and Pluticasone Propionate
GB0015034D0 (en) 2000-06-21 2000-08-09 Glaxo Group Ltd Inhalation device
AR030516A1 (es) * 2000-08-31 2003-08-20 Glaxo Group Ltd Uso de una combinacion de salmeterol y fluticasona
GB0208609D0 (en) * 2002-04-13 2002-05-22 Glaxo Group Ltd Compositions
GB0208608D0 (en) * 2002-04-13 2002-05-22 Glaxo Group Ltd Composition
GB0324918D0 (en) * 2003-10-24 2003-11-26 Glaxo Group Ltd Composition
JP2007509941A (ja) * 2003-10-28 2007-04-19 グラクソ　グループ　リミテッド ラクトース無水物を用いる吸入医薬製剤およびその投与方法
DE102007056263A1 (de) * 2007-11-22 2009-05-28 Siegfried Generics International Ag Dosiervorrichtung zur Inhalierung einer pulverförmigen Substanz
EP2221048A1 (en) * 2009-02-18 2010-08-25 Siegfried Generics International AG Pharmaceutical composition for inhalation
TR201000681A2 (tr) * 2010-01-29 2011-08-22 B�Lg�� Mahmut İnhalasyon yoluyla alınan kuru toz formülasyonları.
WO2011145109A1 (en) * 2010-05-20 2011-11-24 Sun Pharma Advanced Research Company Ltd., Dry powder inhalation composition

Also Published As

Publication number Publication date
ZA201507373B (en) 2017-03-29
KR20160003183A (ko) 2016-01-08
AU2014261538A1 (en) 2015-12-10
BR112015027017A2 (pt) 2017-07-25
RU2015150970A (ru) 2017-06-07
WO2014177519A1 (en) 2014-11-06
US20160158149A1 (en) 2016-06-09
HK1215388A1 (zh) 2016-08-26
CN105324107A (zh) 2016-02-10
JP2016519123A (ja) 2016-06-30
RU2015150970A3 (es) 2018-03-29
EP2991625A1 (en) 2016-03-09

Similar Documents

Publication Publication Date Title
MX2015015132A (es) Composiciones farmaceuticas inhalables y los dispositivos inhaladores que las contienen.
TR201000680A2 (tr) Tiotropyum, formoterol ve budesonid içeren farmasötik bileşimler
MY176176A (en) Dry powder formulation comprising an anticholinergic, a corticosteroid and a beta-adrenergic for administration by inhalation
MY165888A (en) Dry powder formulation comprising a corticosteroid and a beta-adrenergic for administration by inhalation
MY184654A (en) Novel dosage form and formulation of abediterol
IN2014DN11257A (es)
TR201000681A2 (tr) İnhalasyon yoluyla alınan kuru toz formülasyonları.
PH12014502619A1 (en) Novel dosage and formulation
WO2014007770A3 (en) Inhalation compositions comprising corticosteroid and sorbitol
WO2013104892A8 (en) Application of high dose compounds via inhalation
WO2014007781A3 (en) Inhalation compositions
MX2015015150A (es) Composiciones farmaceuticas inhalables y los dispositivos inhaladores que las contienen.
MX2015009891A (es) Composiciones farmaceuticas que comprenden particulas cristalinas de multicomponentes adecuadas para usar en terapia de inhalacion.
WO2011093815A3 (en) Pharmaceutical compositions comprising formoterol and mometasone
CL2015002702A1 (es) Composiciones farmacéuticas micronizadas.
MX373699B (es) Composicion farmaceutica que contiene budesonida y formoterol.
TR200907913A2 (tr) İnhalason yolu ile alınmak üzere kuru toz formunda farmasötik bileşim
UY35900A (es) Nueva dosificación y formulación
WO2011093810A3 (en) Dry powder pharmaceutical composition comprising tiotropium and mometasone
TR201000730A2 (tr) Tiotropyum ve mometazon içeren kuru toz formundaki farmasötik kompozisyon.
TR201000619A2 (tr) Tiotropium ve mometazon içeren kuru toz formundaki farmasötik kompozisyon.
TR201714893A1 (tr) Beta-2 Agonisti ve Kortikosteroid içeren kuru toz bileşimi.
TR201000624A2 (tr) Tiotropium ve flutikazon içeren kuru toz formundaki farmasötik kompozisyon.
TR201000732A2 (tr) Tiotropyum ve budesonid içeren kuru toz formundaki farmasötik kompozisyon
TR201000621A2 (tr) Tiotropium ve budesonid içeren kuru toz formundaki farmasötik kompozisyon